跳至主要内容
临床试验/NCT05013047
NCT05013047Unknown不适用

Impact of the Covid19 Pandemic on the Organization of Healthcare in France

Assistance Publique Hopitaux De Marseille1 个研究点 分布在 1 个国家目标入组 100,000 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100,000
试验地点
1
主要终点
Assess the effect of pandemic COVID-19 on medication compliance in patients with chronic disease

研究概览

简要总结

The 2020 COVID-19 pandemic, which began spreading on January 24, 2020 in France, has required a profound and rapid reorganization of the health system, based in particular on internal hospital reorganizations of front-line establishments, deprogramming of non-urgent activities, and transfers of non-covid19 patients to 2nd line facilities. Beyond the immediate impact on the management of patients infected with COVID-19, this reorganization may have reduced the capacity of management for patients requiring urgent or semi-urgent intervention, or may have postponed some necessary care. The isolation of patients at home may also have resulted in lower compliance to therapy and medical treatments and may have contributed to decompensation.

At the end of this crisis, the different organizational responses in France should be evaluated to identify the consequences and the areas for improvement in order to be prepared for future exceptional health situations. This investigation on healthcare systems confronted to an exceptional health situation thus seeks to determine if the profound reorganizations implemented during this health crisis have indirect effects on the performance of care, in particular if there is a destabilization of the care systems (emergency, semi-emergency and chronic), a loss of chance for the patients and if innovative care paths have emerged.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with one of these three types of chronic diseases (Prevention Quality Indicators of the Agency for Healthcare Research and Quality): heart failure, diabetes, chronic obstructive pulmonary disease.
  • All French adult patients suffering from the studied chronic diseases, covered by the Health Insurance and living in metropolitan France are included.

排除标准

  • Patients under 18 years of age or with incomplete or inconsistent data on the "Système National des Données de Santé", or with a symptomatic COVID-19 diagnosis.

结局指标

主要结局

Assess the effect of pandemic COVID-19 on medication compliance in patients with chronic disease

时间窗: Measured by trimesters (from March 2019 to February 2021)

Combined chronic drug coverage rate calculated on a three-monthly basis (average of the coverage rates for each drug)

次要结局

  • Evaluate the effects of pandemic and lock-down on the risk of decompensation in patients with chronic disease.(6 months period)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验